{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_018653.4:c.6079T>A",
          "cDNA Change": {
            "transcript": "NM_018653.4",
            "ref": "T",
            "alt": "A",
            "position": "6079"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "c.6079T>A (p.Ile2020Thr)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0100840"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell viability assay and Western blot",
      "Material used": {
        "Material Source": "Human embryonic kidney cells (HEK293)",
        "Material Name": "HEK293 cells transfected with LRRK2 constructs",
        "Description": "The experiment was conducted using HEK293 cells transfected with wild-type or mutant LRRK2 constructs."
      },
      "Readout type": "Quantitative and qualitative",
      "Readout description": [
        {
          "Variant": "NM_018653.4:c.6079T>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "dominant-negative",
          "Result Description": "The I2020T mutant showed reduced protective effects against hydrogen peroxide-induced apoptosis compared to the wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate to ensure consistency."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 expression construct was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "Not applicable"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "Not applicable"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Analysis of variance (ANOVA) and Student's t-test were used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}